Pterostilbene attenuates inflammation in rat heart subjected to ischemia-reperfusion: Role of TLR4/NF-κB signaling pathway

International Journal of Clinical and Experimental Medicine

Volumn 8, Issue 2, 2015, Pages 1737-1746

  Wang, Chen ^a   Sun, Hourong ^b   Song, Yi ^b   Ma, Zengshan ^b   Zhang, Gong ^b   Gu, Xinghua ^b   Zhao, Lei ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b SHANDONG UNIVERSITY   (China)

Author keywords

Apoptosis; Ischemia reperfusion injury; Neutrophil; Pterostilbene; TLR4 NF B signaling; TNF

Indexed keywords

ANTIINFLAMMATORY AGENT; CASPASE 3; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MYELOPEROXIDASE; NITRIC OXIDE SYNTHASE INHIBITOR; PROTEIN BCL 2; PTEROSTILBENE; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MALE; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; NICK END LABELING; NONHUMAN; PROTEIN EXPRESSION; RAT; REPERFUSION INJURY; SIGNAL TRANSDUCTION; UPREGULATION; WESTERN BLOTTING;

RATTUS;

EID: 84926302113     PISSN: None     EISSN: 19405901     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. [1] Xiong J, Xue FS, Yuan YJ, Wang Q, Liao X and Wang WL. Cholinergic anti-inflammatory pathway: a possible approach to protect against myocardial ischemia reperfusion injury. Chin Med J (Engl) 2010; 123: 2720-2726.
2. [2] Naidu BV, Farivar AS, Woolley SM, Grainger D, Verrier ED and Mulligan MS. Novel broad-spectrum chemokine inhibitor protects against lung ischemia-reperfusion injury. J Heart Lung Transplant 2004; 23: 128-134.
3. [3] Batista ML Jr, Rosa JC, Lopes RD, Lira FS, Martins E Jr, Yamashita AS, Brum PC, Lancha AH Jr, Lopes AC and Seelaender M. Exercise training changes IL-10/TNF-alpha ratio in the skeletal muscle of post-MI rats. Cytokine 2010; 49: 102-108.
4. [4] Shimamoto A, Chong AJ, Yada M, Shomura S, Takayama H, Fleisig AJ, Agnew ML, Hampton CR, Rothnie CL, Spring DJ, Pohlman TH, Shimpo H and Verrier ED. Inhibition of Toll-like receptor 4 with eritoran attenuates myocardial ischemia-reperfusion injury. Circulation 2006; 114: I270-274.
5. [5] Kawai T and Akira S. Signaling to NF-kappaB by Toll-like receptors. Trends Mol Med 2007; 13: 460-469.
6. [6] Kaisho T and Akira S. Toll-like receptor function and signaling. J Allergy Clin Immunol 2006; 117: 979-987; quiz 988.
7. [7] Arumugam TV, Okun E, Tang SC, Thundyil J, Taylor SM and Woodruff TM. Toll-like receptors in ischemia-reperfusion injury. Shock 2009; 32: 4-16.
8. [8] Kaczorowski DJ, Nakao A, McCurry KR and Billiar TR. Toll-like receptors and myocardial ischemia/reperfusion, inflammation, and injury. Curr Cardiol Rev 2009; 5: 196-202.
9. [9] Smiley ST, King JA and Hancock WW. Fibrinogen stimulates macrophage chemokine secretion through toll-like receptor 4. J Immunol 2001; 167: 2887-2894.
10. [10] Yu M, Wang H, Ding A, Golenbock DT, Latz E, Czura CJ, Fenton MJ, Tracey KJ and Yang H. HMGB1 signals through toll-like receptor (TLR) 4 and TLR2. Shock 2006; 26: 174-179.
11. [11] Imai Y, Kuba K, Neely GG, Yaghubian-Malhami R, Perkmann T, van Loo G, Ermolaeva M, Veldhuizen R, Leung YH, Wang H, Liu H, Sun Y, Pasparakis M, Kopf M, Mech C, Bavari S, Peiris JS, Slutsky AS, Akira S, Hultqvist M, Holmdahl R, Nicholls J, Jiang C, Binder CJ and Penninger JM. Identification of oxidative stress and Toll-like receptor 4 signaling as a key pathway of acute lung injury. Cell 2008; 133: 235-249.
12. [12] Frantz S, Kobzik L, Kim YD, Fukazawa R, Medzhitov R, Lee RT and Kelly RA. Toll4 (TLR4) expression in cardiac myocytes in normal and failing myocardium. J Clin Invest 1999; 104: 271-280.
13. [13] Roupe KA, Remsberg CM, Yanez JA and Davies NM. Pharmacometrics of stilbenes: seguing towards the clinic. Curr Clin Pharmacol 2006; 1: 81-101.
14. [14] Lin HS, Yue BD and Ho PC. Determination of pterostilbene in rat plasma by a simple HPLC-UV method and its application in pre-clinical pharmacokinetic study. Biomed Chromatogr 2009; 23: 1308-1315.
15. [15] Kapetanovic IM, Muzzio M, Huang Z, Thompson TN and McCormick DL. Pharmacokinetics, oral bioavailability, and metabolic profile of resveratrol and its dimethylether analog, pterostilbene, in rats. Cancer Chemother Pharmacol 2011; 68: 593-601.
16. [16] Perecko T, Drabikova K, Rackova L, Ciz M, Podborska M, Lojek A, Harmatha J, Smidrkal J, Nosal R and Jancinova V. Molecular targets of the natural antioxidant pterostilbene: effect on protein kinase C, caspase-3 and apoptosis in human neutrophils in vitro. Neuro Endocrinol Lett 2010; 31 Suppl 2: 84-90.
17. [17] Athar M, Back JH, Tang X, Kim KH, Kopelovich L, Bickers DR and Kim AL. Resveratrol: a review of preclinical studies for human cancer prevention. Toxicol Appl Pharmacol 2007; 224: 274-283.
18. [18] McCormack D and McFadden D. A review of pterostilbene antioxidant activity and disease modification. Oxid Med Cell Longev 2013; 2013: 575482.
19. [19] McCormack D and McFadden D. Pterostilbene and cancer: current review. J Surg Res 2012; 173: e53-61.
20. [20] Su H, Sun X, Ma H, Zhang HF, Yu QJ, Huang C, Wang XM, Luan RH, Jia GL, Wang HC and Gao F. Acute hyperglycemia exacerbates myocardial ischemia/reperfusion injury and blunts cardioprotective effect of GIK. Am J Physiol Endocrinol Metab 2007; 293: E629-635.
21. [21] Speyer CL and Ward PA. Role of endothelial chemokines and their receptors during inflammation. J Invest Surg 2011; 24: 18-27.
22. [22] Khimenko PL, Bagby GJ, Fuseler J and Taylor AE. Tumor necrosis factor-alpha in ischemia and reperfusion injury in rat lungs. J Appl Physiol (1985) 1998; 85: 2005-2011.
23. [23] Zhu J, Liu M, Kennedy RH and Liu SJ. TNF-alpha-induced impairment of mitochondrial integrity and apoptosis mediated by caspase-8 in adult ventricular myocytes. Cytokine 2006; 34: 96-105.
24. [24] Meldrum DR, Cleveland JC Jr, Cain BS, Meng X and Harken AH. Increased myocardial tumor necrosis factor-alpha in a crystalloid-perfused model of cardiac ischemia-reperfusion injury. Ann Thorac Surg 1998; 65: 439-443.
25. [25] Gurevitch J, Frolkis I, Yuhas Y, Lifschitz-Mercer B, Berger E, Paz Y, Matsa M, Kramer A and Mohr R. Anti-tumor necrosis factor-alpha improves myocardial recovery after ischemia and reperfusion. J Am Coll Cardiol 1997; 30: 1554-1561.
26. [26] Lefer AM, Ma XL, Weyrich A and Lefer DJ. Endothelial dysfunction and neutrophil adherence as critical events in the development of reperfusion injury. Agents Actions Suppl 1993; 41: 127-135.
27. [27] Ma XL, Lefer DJ, Lefer AM and Rothlein R. Coronary endothelial and cardiac protective effects of a monoclonal antibody to intercellular adhesion molecule-1 in myocardial ischemia and reperfusion. Circulation 1992; 86: 937-946.
28. [28] Chandrasekar B, Smith JB and Freeman GL. Ischemia-reperfusion of rat myocardium activates nuclear factor-KappaB and induces neutrophil infiltration via lipopolysaccharide-induced CXC chemokine. Circulation 2001; 103: 2296-2302.
29. [29] Otsui K, Inoue N, Kobayashi S, Shiraki R, Honjo T, Takahashi M, Hirata K, Kawashima S and Yokoyama M. Enhanced expression of TLR4 in smooth muscle cells in human atherosclerotic coronary arteries. Heart Vessels 2007; 22: 416-422.
30. [30] Ha T, Li Y, Hua F, Ma J, Gao X, Kelley J, Zhao A, Haddad GE, Williams DL, William Browder I, Kao RL and Li C. Reduced cardiac hypertrophy in toll-like receptor 4-deficient mice following pressure overload. Cardiovasc Res 2005; 68: 224-234.
31. [31] Takahashi T. Toll-like receptors and myocardial contractile dysfunction. Cardiovasc Res 2008; 78: 3-4.
32. [32] Hoshino K, Takeuchi O, Kawai T, Sanjo H, Ogawa T, Takeda Y, Takeda K and Akira S. Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J Immunol 1999; 162: 3749-3752.
33. [33] Liu YY, Cai WF, Yang HZ, Cui B, Chen ZR, Liu HZ, Yan J, Jin W, Yan HM, Xin BM, Yuan B, Hua F and Hu ZW. Bacillus Calmette-Guerin and TLR4 agonist prevent cardiovascular hypertrophy and fibrosis by regulating immune microenvironment. J Immunol 2008; 180: 7349-7357.
34. [34] Liu P, Hock CE, Nagele R and Wong PY. Formation of nitric oxide, superoxide, and peroxynitrite in myocardial ischemia-reperfusion injury in rats. Am J Physiol 1997; 272: H2327-2336.
35. [35] Li J, Wu F, Zhang H, Fu F, Ji L, Dong L, Li Q, Liu W, Zhang Y, Lv A, Wang H, Ren J and Gao F. Insulin inhibits leukocyte-endothelium adherence via an Akt-NO-dependent mechanism in myocardial ischemia/reperfusion. J Mol Cell Cardiol 2009; 47: 512-519.
36. [36] Li J, Zhang H, Wu F, Nan Y, Ma H, Guo W, Wang H, Ren J, Das UN and Gao F. Insulin inhibits tumor necrosis factor-alpha induction in myocardial ischemia/reperfusion: role of Akt and endothelial nitric oxide synthase phosphorylation. Crit Care Med 2008; 36: 1551-1558.